Clinical Trials Browser

Interventional × Adenoma × Dermatologic × Clear all

NCT06398418 2025-09-04

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Phase 1 Recruiting

Adenoma, Melanoma, Neoplasms, Basal Cell, Neoplasms, Squamous Cell